Literature DB >> 15941913

How I treat idiopathic thrombocytopenic purpura (ITP).

Douglas B Cines1, James B Bussel.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15941913     DOI： 10.1182/blood-2004-12-4598

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  73 in total

1.  Rituximab in immune thrombocytopenia: transient responses, low rate of sustained remissions and poor response to further therapy in refractory patients.

Authors:  Aamer Aleem; Ahmed S Alaskar; Farja Algahtani; Mushtaq Rather; Muhamad Hitham Almahayni; Abdulkarim Al-Momen
Journal:  Int J Hematol       Date:  2010-07-17       Impact factor: 2.490

2.  Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia.

Authors:  Rojin Park
Journal:  Blood Res       Date:  2015-03

3.  Stimulating platelet production to raise platelet count in immune thrombocytopenic purpura: A novel approach.

Authors:  Jagdish Chandra; V P Choudhry
Journal:  Indian J Pediatr       Date:  2009-10       Impact factor: 1.967

Review 4.  Pathophysiology and therapeutic options in primary immune thrombocytopenia.

Authors:  Roberto Stasi
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

5.  CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia.

Authors:  Li Ma; Elisa Simpson; June Li; Min Xuan; Miao Xu; Laura Baker; Yan Shi; Issaka Yougbaré; Xiaozhong Wang; Guangheng Zhu; Pingguo Chen; Gerald J Prud'homme; Alan H Lazarus; John Freedman; Heyu Ni
Journal:  Blood       Date:  2015-06-02       Impact factor: 22.113

6.  Prolonged remission from eltrombopag in chronic refractory idiopathic thrombocytopenic purpura.

Authors:  V Noronha; S D Philip; A Joshi; K Prabhash
Journal:  Int J Hematol       Date:  2012-08-01       Impact factor: 2.490

Review 7.  Laparoscopic splenectomy for primary immune thrombocytopenia: Current status and challenges.

Authors:  Dong Zheng; Chen-Song Huang; Shao-Bin Huang; Chao-Xu Zheng
Journal:  World J Gastrointest Endosc       Date:  2016-09-16

Review 8.  Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura.

Authors:  Roberto Stasi; Maria L Evangelista; Sergio Amadori
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle.

Authors:  Andreas Rank; Oliver Weigert; Helmut Ostermann
Journal:  Biologics       Date:  2010-05-25

Review 10.  Immune thrombocytopenia in pregnancy.

Authors:  Evi Stavrou; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2009-12       Impact factor: 3.722
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.